nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—Ileus paralytic—Vincristine—peripheral nervous system neoplasm	0.0348	0.0355	CcSEcCtD
Benzatropine—Memory impairment—Tretinoin—peripheral nervous system neoplasm	0.0263	0.0268	CcSEcCtD
Benzatropine—Memory impairment—Isotretinoin—peripheral nervous system neoplasm	0.0263	0.0268	CcSEcCtD
Benzatropine—Ileus—Vincristine—peripheral nervous system neoplasm	0.0213	0.0217	CcSEcCtD
Benzatropine—Memory impairment—Alitretinoin—peripheral nervous system neoplasm	0.0199	0.0203	CcSEcCtD
Benzatropine—Cerebrovascular accident—Isotretinoin—peripheral nervous system neoplasm	0.0153	0.0156	CcSEcCtD
Benzatropine—Cerebrovascular accident—Tretinoin—peripheral nervous system neoplasm	0.0153	0.0156	CcSEcCtD
Benzatropine—Psychotic disorder—Tretinoin—peripheral nervous system neoplasm	0.0146	0.0149	CcSEcCtD
Benzatropine—Psychotic disorder—Isotretinoin—peripheral nervous system neoplasm	0.0146	0.0149	CcSEcCtD
Benzatropine—Trimethaphan—BCHE—peripheral nervous system neoplasm	0.0132	0.632	CrCbGaD
Benzatropine—Dysphagia—Tretinoin—peripheral nervous system neoplasm	0.0129	0.0132	CcSEcCtD
Benzatropine—Dysphagia—Isotretinoin—peripheral nervous system neoplasm	0.0129	0.0132	CcSEcCtD
Benzatropine—Dysuria—Tretinoin—peripheral nervous system neoplasm	0.0121	0.0123	CcSEcCtD
Benzatropine—Dysuria—Isotretinoin—peripheral nervous system neoplasm	0.0121	0.0123	CcSEcCtD
Benzatropine—Cerebrovascular accident—Alitretinoin—peripheral nervous system neoplasm	0.0116	0.0118	CcSEcCtD
Benzatropine—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.0111	0.0113	CcSEcCtD
Benzatropine—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.0106	0.0108	CcSEcCtD
Benzatropine—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.0104	0.0106	CcSEcCtD
Benzatropine—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.0104	0.0106	CcSEcCtD
Benzatropine—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0105	CcSEcCtD
Benzatropine—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0105	CcSEcCtD
Benzatropine—Cerebrovascular accident—Cisplatin—peripheral nervous system neoplasm	0.00986	0.0101	CcSEcCtD
Benzatropine—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.0098	0.01	CcSEcCtD
Benzatropine—Ileus—Epirubicin—peripheral nervous system neoplasm	0.00965	0.00986	CcSEcCtD
Benzatropine—Dysuria—Alitretinoin—peripheral nervous system neoplasm	0.00916	0.00936	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—peripheral nervous system neoplasm	0.00893	0.00912	CcSEcCtD
Benzatropine—Tension—Tretinoin—peripheral nervous system neoplasm	0.00884	0.00903	CcSEcCtD
Benzatropine—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00884	0.00903	CcSEcCtD
Benzatropine—Dysuria—Vincristine—peripheral nervous system neoplasm	0.00883	0.00902	CcSEcCtD
Benzatropine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00875	0.00894	CcSEcCtD
Benzatropine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00875	0.00894	CcSEcCtD
Benzatropine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00849	0.00867	CcSEcCtD
Benzatropine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00849	0.00867	CcSEcCtD
Benzatropine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.0078	0.00797	CcSEcCtD
Benzatropine—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.00765	0.00781	CcSEcCtD
Benzatropine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.00752	0.00768	CcSEcCtD
Benzatropine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.0075	0.00766	CcSEcCtD
Benzatropine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.0075	0.00766	CcSEcCtD
Benzatropine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00741	0.00757	CcSEcCtD
Benzatropine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00741	0.00757	CcSEcCtD
Benzatropine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00717	0.00733	CcSEcCtD
Benzatropine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00717	0.00733	CcSEcCtD
Benzatropine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00708	0.00723	CcSEcCtD
Benzatropine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.0067	0.00684	CcSEcCtD
Benzatropine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00663	0.00677	CcSEcCtD
Benzatropine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00644	0.00658	CcSEcCtD
Benzatropine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00643	0.00657	CcSEcCtD
Benzatropine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00639	0.00653	CcSEcCtD
Benzatropine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00639	0.00653	CcSEcCtD
Benzatropine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00634	0.00647	CcSEcCtD
Benzatropine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00631	0.00644	CcSEcCtD
Benzatropine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00629	0.00642	CcSEcCtD
Benzatropine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00629	0.00642	CcSEcCtD
Benzatropine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00611	0.00624	CcSEcCtD
Benzatropine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00609	0.00622	CcSEcCtD
Benzatropine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00606	0.00619	CcSEcCtD
Benzatropine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00606	0.00619	CcSEcCtD
Benzatropine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00586	0.00598	CcSEcCtD
Benzatropine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00581	0.00594	CcSEcCtD
Benzatropine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00581	0.00594	CcSEcCtD
Benzatropine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00568	0.00581	CcSEcCtD
Benzatropine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00562	0.00574	CcSEcCtD
Benzatropine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00548	0.0056	CcSEcCtD
Benzatropine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00546	0.00558	CcSEcCtD
Benzatropine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00544	0.00555	CcSEcCtD
Benzatropine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00542	0.00553	CcSEcCtD
Benzatropine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00542	0.00553	CcSEcCtD
Benzatropine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00535	0.00546	CcSEcCtD
Benzatropine—Reboxetine—ABCB1—peripheral nervous system neoplasm	0.00527	0.252	CrCbGaD
Benzatropine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00522	0.00533	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.00506	0.00517	CcSEcCtD
Benzatropine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00495	0.00506	CcSEcCtD
Benzatropine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00484	0.00495	CcSEcCtD
Benzatropine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00476	0.00487	CcSEcCtD
Benzatropine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00475	0.00485	CcSEcCtD
Benzatropine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00471	0.00481	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.00468	0.00478	CcSEcCtD
Benzatropine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00467	0.00477	CcSEcCtD
Benzatropine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00467	0.00477	CcSEcCtD
Benzatropine—Rash—Topotecan—peripheral nervous system neoplasm	0.00467	0.00477	CcSEcCtD
Benzatropine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00467	0.00477	CcSEcCtD
Benzatropine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00467	0.00477	CcSEcCtD
Benzatropine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00464	0.00473	CcSEcCtD
Benzatropine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00464	0.00473	CcSEcCtD
Benzatropine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00463	0.00473	CcSEcCtD
Benzatropine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00463	0.00473	CcSEcCtD
Benzatropine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00463	0.00473	CcSEcCtD
Benzatropine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00461	0.00471	CcSEcCtD
Benzatropine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00459	0.00469	CcSEcCtD
Benzatropine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00459	0.00469	CcSEcCtD
Benzatropine—Rash—Melphalan—peripheral nervous system neoplasm	0.00458	0.00467	CcSEcCtD
Benzatropine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00457	0.00467	CcSEcCtD
Benzatropine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00443	0.00452	CcSEcCtD
Benzatropine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.0044	0.0045	CcSEcCtD
Benzatropine—Nausea—Topotecan—peripheral nervous system neoplasm	0.0044	0.0045	CcSEcCtD
Benzatropine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00439	0.00448	CcSEcCtD
Benzatropine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00437	0.00446	CcSEcCtD
Benzatropine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00437	0.00446	CcSEcCtD
Benzatropine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00431	0.0044	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00429	0.00438	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00424	0.00433	CcSEcCtD
Benzatropine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00424	0.00433	CcSEcCtD
Benzatropine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00413	0.00421	CcSEcCtD
Benzatropine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.0041	0.00419	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00401	0.00409	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00397	0.00405	CcSEcCtD
Benzatropine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00396	0.00404	CcSEcCtD
Benzatropine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00391	0.004	CcSEcCtD
Benzatropine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00382	0.0039	CcSEcCtD
Benzatropine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00379	0.00387	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00378	0.00386	CcSEcCtD
Benzatropine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00375	0.00383	CcSEcCtD
Benzatropine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00372	0.0038	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00371	0.00379	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00358	0.00366	CcSEcCtD
Benzatropine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00357	0.00365	CcSEcCtD
Benzatropine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00354	0.00362	CcSEcCtD
Benzatropine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00351	0.00359	CcSEcCtD
Benzatropine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00351	0.00358	CcSEcCtD
Benzatropine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0035	0.00357	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00344	0.00351	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00341	0.00349	CcSEcCtD
Benzatropine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00341	0.00349	CcSEcCtD
Benzatropine—Rash—Vincristine—peripheral nervous system neoplasm	0.00338	0.00346	CcSEcCtD
Benzatropine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00338	0.00345	CcSEcCtD
Benzatropine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00331	0.00338	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0032	0.00327	CcSEcCtD
Benzatropine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00319	0.00326	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00316	0.00323	CcSEcCtD
Benzatropine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00302	0.00308	CcSEcCtD
Benzatropine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00299	0.00306	CcSEcCtD
Benzatropine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00299	0.00305	CcSEcCtD
Benzatropine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00299	CcSEcCtD
Benzatropine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.0029	0.00296	CcSEcCtD
Benzatropine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00282	0.00288	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00282	0.00288	CcSEcCtD
Benzatropine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00277	0.00282	CcSEcCtD
Benzatropine—Rash—Etoposide—peripheral nervous system neoplasm	0.00274	0.0028	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00274	0.0028	CcSEcCtD
Benzatropine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00277	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00268	0.00274	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.0026	0.00266	CcSEcCtD
Benzatropine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00258	0.00264	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00249	0.00254	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00251	CcSEcCtD
Benzatropine—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.00241	0.116	CrCbGaD
Benzatropine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00238	0.00243	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.0023	0.00235	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00232	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.0022	0.00225	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00212	0.00216	CcSEcCtD
Benzatropine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00208	0.00213	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00201	0.00205	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.002	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00193	0.00197	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00193	0.00197	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.0019	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.0018	0.00183	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00178	0.00182	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.0017	CcSEcCtD
Benzatropine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00158	CcSEcCtD
Benzatropine—Rash—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00157	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00157	CcSEcCtD
Benzatropine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00148	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00143	0.00146	CcSEcCtD
Benzatropine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00145	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00145	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00137	CcSEcCtD
